Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Hindson

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Nature Reviews. Gastroenterology & Hepatology|April 3, 2023
Rifaximin-α for ALD: phase II resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|April 3, 2023
Comparing elimination diet therapies for eosinophilic oesophagitisJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|August 8, 2023
Microbiomes of Hadza hunter-gatherersJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|August 8, 2023
Bulevirtide for chronic hepatitis D: phase III dataJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|June 30, 2022
Tirzepatide to treat obesity: phase III resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|September 9, 2024
Characterizing the genomic landscape of colorectal cancerJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|May 15, 2024
Telemedicine for hepatitis C virus treatment in opioid treatment programmesJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|February 12, 2024
Linaclotide for functional constipation in paediatric patients: phase III resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|November 5, 2025
Predicting mortality in cirrhosisJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|March 13, 2025
EASL Liver Cancer Summit 2025Jordan Hindson
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Nature Reviews. Gastroenterology & Hepatology|April 3, 2023
Rifaximin-α for ALD: phase II resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|April 3, 2023
Comparing elimination diet therapies for eosinophilic oesophagitisJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|August 8, 2023
Microbiomes of Hadza hunter-gatherersJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|August 8, 2023
Bulevirtide for chronic hepatitis D: phase III dataJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|June 30, 2022
Tirzepatide to treat obesity: phase III resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|September 9, 2024
Characterizing the genomic landscape of colorectal cancerJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|May 15, 2024
Telemedicine for hepatitis C virus treatment in opioid treatment programmesJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|February 12, 2024
Linaclotide for functional constipation in paediatric patients: phase III resultsJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|November 5, 2025
Predicting mortality in cirrhosisJordan Hindson
Nature Reviews. Gastroenterology & Hepatology|March 13, 2025
EASL Liver Cancer Summit 2025Jordan Hindson
Pageof 13